This article is more than 5 years old. Information may no longer be current.

Limited macular translocation aids vision in some patients at 1 year

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

LOS ANGELES — Limited macular translocation shows promise for some age-related macular degeneration patients at 1 year follow-up.

The retinal procedure was associated with improved visual acuity in about 40% of eyes, investigators said. Further, the procedure enables complete laser photocoagulation of the neovascular complex with sparing of the sensory macula in just over 60% of eyes that complete 1-year follow-up, according to Eugene de Juan Jr., MD, and colleagues here at the Doheny Retina Institute.

Dr. de Juan conducted a retrospective review of 102 consecutive eyes of 101 patients that had the inferior limited macular translocation procedure for subfoveal choroidal neovascularization (CNV) secondary to AMD.

Of the 102 eyes, 86 completed the 1-year follow-up, with 35 achieving visual acuity of 20/100 or better and 34 experiencing visual improvement of 2 or more Snellen lines. In 52 eyes with effective translocation and complete laser photocoagulation of the CNV complex, the incidence of recurrence of CNV was 35% at 12 months.

The study is published in the July issue of American Journal of Ophthalmology.